These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8390012)

  • 1. Hyaluronic acid metabolism and its clinical significance in patients treated by continuous ambulatory peritoneal dialysis.
    Lipkin GW; Forbes MA; Cooper EH; Turney JH
    Nephrol Dial Transplant; 1993; 8(4):357-60. PubMed ID: 8390012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
    Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
    Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients.
    Passadakis P; Panagoutsos S; Thodis E; Tsivara I; Sopassi F; Kartali S; Vargemezis V
    Adv Perit Dial; 1999; 15():40-4. PubMed ID: 10682070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional parameters in diabetic patients on CAPD.
    Scanziani R; Dozio B; Bonforte G; Surian M
    Adv Perit Dial; 1996; 12():280-3. PubMed ID: 8865919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient and technique survival in continuous ambulatory peritoneal dialysis in a single center of the west of Mexico.
    Rojas-Campos E; Alcántar-Medina M; Cortés-Sanabria L; Martínez-Ramírez HR; Camarena JL; Chávez S; Flores A; Nieves JJ; Monteón F; Gómez-Navarro B; Cueto-Manzano AM
    Rev Invest Clin; 2007; 59(3):184-91. PubMed ID: 17910410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
    Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
    Kim S; Oh J; Kim S; Chung W; Ahn C; Kim SG; Oh KH
    Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of central hypothyroidism in children on continuous ambulatory peritoneal dialysis.
    Düsünsel R; Poyrazoglu HM; Gündüz Z; Kurtoglu S; Kiris A; Günes T
    Adv Perit Dial; 1999; 15():262-8. PubMed ID: 10682115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
    Nakamoto H; Takane H; Sugahara S; Kanno Y; Okada H; Yamamoto T; Suzuki H
    Adv Perit Dial; 2003; 19():97-102. PubMed ID: 14763042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino-acid-based dialysis solution changes leptinemia and leptin peritoneal clearance.
    Grzegorzewska AE; Wiecek A; Mariak I; Kokot F
    Adv Perit Dial; 2000; 16():7-14. PubMed ID: 11045252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bidirectional peritoneal transport of albumin in continuous ambulatory peritoneal dialysis.
    Joffe P; Henriksen JH
    Nephrol Dial Transplant; 1995; 10(9):1725-32. PubMed ID: 8559496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peritoneal dialysis in the aged].
    Stojimirović B; Nesić V; Dimitrijević Z; Jovanović N
    Med Pregl; 1999; 52(9-10):369-74. PubMed ID: 10624386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of hyaluronic acid by human peritoneal mesothelial cells: effect of cytokines and dialysate.
    Breborowicz A; Korybalska K; Grzybowski A; Wieczorowska-Tobis K; Martis L; Oreopoulos DG
    Perit Dial Int; 1996; 16(4):374-8. PubMed ID: 8863330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid in end-stage renal failure treated by haemodialysis: clinical correlates and implications.
    Turney JH; Davison AM; Forbes MA; Cooper EH
    Nephrol Dial Transplant; 1991; 6(8):566-70. PubMed ID: 1956556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of hyaluronan in man.
    Laurent TC; Lilja K; Brunnberg L; Engström-Laurent A; Laurent UB; Lindqvist U; Murata K; Ytterberg D
    Scand J Clin Lab Invest; 1987 Dec; 47(8):793-9. PubMed ID: 3433001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid in end-stage renal disease treated by hemodialysis.
    Orasan OH; Orasan RA; Patiu IM; Dumitrascu DL
    Ren Fail; 2015; 37(9):1531-2. PubMed ID: 26337537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.